PATENT CLAIM ANALYSIS

Application Number: 16285560
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["544", "333000"]

Abstract:
There are provided compounds of formula (I) which are inhibitors of the family of p38 mitogen-activated protein kinase enzymes, and to their use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, such as asthma and COPD.

Claim (Index 9):
A pharmaceutical composition comprising a compound according to any one of  claims 1  to  8 , in combination with one or more pharmaceutically acceptable diluents or carriers.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 99.0
- Lexical Diversity: 1.44737
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15636730', '15925384', '14349356', '15259505', '14424361']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8212869810013776
- 35 USC 102 Novelty (BERT): 0.6224998459950771
- Combined Prediction Score: 0.8014082675007476
- Mean Citation Score: 568.4646060000001
- Max Citation Score: 588.35767
- Similarity Product: 528.3861491989112

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test